ArticleHealth science reports2026
The Role of Pharmacists in Tackling Mpox: Challenges and Future Prospects: A Narrative Review.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Pharmacists play a key role in managing and mitigating mpox through clinical care, pharmacovigilance, vaccine management, and resilient supply chains. Management focuses on supportive care, infection prevention, and accurate diagnosis, with pharmacists ensuring the availability and rational use of vaccines, disinfectants, laboratory reagents, and personal protective equipment. They also promote vaccine equity, community engagement, pharmacovigilance, and efficient production and distribution of health commodities. In Africa, where 1.2 billion people lack access to mpox vaccines, pharmacists help address inequities through community outreach and trust-building. They further strengthen supply chains using inventory management, local production, and technologies such as artificial intelligence, blockchain, and continuous manufacturing. Pharmacists support humanitarian supply chains by promoting rational medicine use, preventing antimicrobial resistance, and supporting adherence. However, their impact is limited by vaccine inequities, varying clinical authority, inadequate training, and limited involvement in outbreak planning. Expanding their roles in surveillance, pharmacoeconomics, and real-world evidence is crucial to improve outcomes and cost-effectiveness. Looking ahead, pharmacists are essential in smallpox and mpox vaccine research, contributing to safety and efficacy through involvement in drug development and clinical trials. Methods: This narrative review employs a thematic synthesis to evaluate the pharmacist's role in the global mpox response. By analyzing literature from major databases (PubMed, Scopus, and Google Scholar) and technical reports, it identifies systemic opportunities and structural challenges within the pharmaceutical lifecycle. Conclusion: Integrating pharmacists into multidisciplinary teams and enhancing their training in pharmacovigilance and infectious disease management are critical to achieving sustainable outbreak preparedness. Empowering pharmacists through structural reforms can enhance health system resilience, optimize cost, and safeguard public health in current and future pandemics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.